Nuntius Therapeutics raises €113K Seed round
22 March 2021· London, United Kingdom· health, biotech, ai, materials, b2b, software_hardware
Nuntius Therapeutics develops transformative mRNA therapies using proprietary delivery technology to target life-threatening diseases like cancer and neurodegenerative disorders.
Investors
LeadY Combinator
Also participating
Backed VCFoundersX VenturesAsymmetry VenturesUncommon DenominatorEight CapitalSavantus Ventures
About Nuntius Therapeutics
Stage
Seed
Headquarters
London, United Kingdom
Founded
2021
Team Size
6–20
Sectors
healthbiotechaimaterialsb2bsoftware_hardware